Glenmede Trust CO Na Cytom X Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

  • $20.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$6.47 - $7.9 $6,961 - $8,500
-1,076 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$5.17 - $8.91 $956 - $1,648
185 Added 20.76%
1,076 $8,000
Q3 2019

Nov 14, 2019
SELL
$7.38 - $12.25 $1,778 - $2,952
-241 Reduced 21.29%
891 $6,000
Q2 2019

Aug 13, 2019
BUY
$9.35 - $11.41 $10,584 - $12,916
1,132 New
1,132 $12,000

Others Institutions Holding CTMX

# of Institutions
69
Shares Held
50.4M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $60M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email